红细胞-ROS轴在血栓形成和血液静止中
Serena Borghi1, Francesca Nencini1, Elvira Giurranna1
1Department of Experimental and Clinical Biomedical Sciences "Mario Serio," University of Firenze, Firenze, Italy.
Seminars in thrombosis and hemostasis
|May 30, 2025
概括
红细胞或红细胞通过氧化压力积极促进血块形成. 这项研究探讨了红细胞的氧化还原生物学如何影响血栓形成和血液静止.
科学领域:
- 血液学 血液学 血液学
- 心血管生物学 心血管生物学
- 转毒生物学 转毒生物学
背景情况:
- 红细胞传统上被认为是凝血过程中被动的.
- 新出现的证据表明,红细胞通过氧化还原机制积极参与血栓形成.
研究的目的:
- 审查红细胞氧化应激对血栓形成和血液静止的多方面的影响.
- 探索对心血管,代谢和血液病的影响.
主要方法:
- 关于红细胞氧化还原生物学和血栓形成的当前文献的综述.
- 分析了将红细胞氧化应激与原血栓状况联系起来的机制.
主要成果:
- 红细胞产生反应性氧和物种 (RONS),促进原血栓现象型.
- 氧化应激改变了红细胞的结构,功能和血液学,增强了血块的形成.
- 红细胞衍生的微囊细胞有助于血栓生成和纤维素形成.
结论:
- 红细胞-ROS轴是血栓形成的关键因素.
- 向红细胞氧化还原稳定可能为血栓形成风险提供新的治疗策略.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
9.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.3K
Erythropoiesis
4.9K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.9K
Factors Affecting Erythropoiesis
3.7K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.7K
Lifecycle of Erythrocytes
2.4K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
2.4K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
932
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
932


